IPCALAB — Ipca Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹410.57bn
- IN₹421.10bn
- IN₹96.46bn
Annual cashflow statement for Ipca Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 11,357 | 7,453 | 8,427 | 11,311 | 15,725 |
| Depreciation | |||||
| Non-Cash Items | -373 | -264 | 1,326 | 3,301 | -1,408 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4,707 | -1,747 | -3,114 | -5,377 | -7,079 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8,602 | 8,058 | 10,212 | 13,213 | 11,420 |
| Capital Expenditures | -4,790 | -4,945 | -4,113 | -7,756 | -6,560 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3,761 | -2,305 | -8,805 | -939 | 4,092 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8,551 | -7,250 | -12,918 | -8,695 | -2,468 |
| Financing Cash Flow Items | -61.8 | -415 | -1,343 | -744 | -816 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4,268 | 5,072 | -5,526 | -2,830 | -7,535 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4,319 | 5,881 | -8,232 | 1,688 | 1,417 |